| Financial Year |
March 31 2023 |
| Monetary Funds |
730,875,167.57 |
| Held-for-trading Financial Assets |
101,243.30 |
| Notes Receivable |
1,091,436,233.18 |
| Accounts Receivable |
2,215,041,044.75 |
| Advances to Suppliers |
99,403,601.92 |
| Other Receivables |
66,737,417.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,133,160,329.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
85,965,918.08 |
| Total Current Assets |
7,902,579,212.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
12,532,787.29 |
| Fixed Assetes |
3,467,963,112.69 |
| Under-construction Projects |
252,113,503.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
478,443,113.27 |
| R&D expenses |
736,170.96 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,428,426.25 |
| Deferred Income Tax Assets |
105,408,093.14 |
| Other Non-Current Assets |
195,415,560.25 |
| Sub-Total of Non-Current Assets |
4,638,061,043.00 |
| Total Assets |
12,540,640,255.83 |
| Short-Term Loans |
929,788,645.97 |
| Trading Financial liabilities |
4,871,308.54 |
| Notes Payable |
96,508,764.12 |
| Accounts Payable |
1,264,916,203.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
112,837,433.95 |
| Taxes Payable |
53,034,788.69 |
| Interest Payable |
2,448,943.07 |
| Dividend Payable |
755,034.53 |
| Other payables |
208,514,012.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
515,618,951.63 |
| Other Current Liabilities |
939,231,973.85 |
| Sub-Total of Current Liabilities |
4,361,573,922.71 |
| Long-term Loans |
1,445,042,888.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
44,751,590.13 |
| Other Non-Current Liabilities |
3,046,309.43 |
| Sub-Total of Non-Current Liabilities |
1,925,964,915.71 |
| Total Liabilities |
6,287,538,838.42 |
| Paid-In Capital(Or Share Stock) |
1,075,526,842.00 |
| Capital Surplus |
3,530,556,287.94 |
| Surplus Reserve |
67,116,750.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
922,667,613.97 |
| Minority Stockholder's Interest |
756,687,374.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,496,414,043.12 |
| Owner's Equity（Stockholder's Equity） |
6,253,101,417.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,540,640,255.83 |
